rs9833
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014263.4(YME1L1):c.*45C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.836 in 1,610,184 control chromosomes in the GnomAD database, including 563,828 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.86 ( 55993 hom., cov: 32)
Exomes 𝑓: 0.83 ( 507835 hom. )
Consequence
YME1L1
NM_014263.4 3_prime_UTR
NM_014263.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.02
Publications
18 publications found
Genes affected
YME1L1 (HGNC:12843): (YME1 like 1 ATPase) The protein encoded by this gene is the human ortholog of yeast mitochondrial AAA metalloprotease, Yme1p. It is localized in the mitochondria and can functionally complement a yme1 disruptant yeast strain. It is proposed that this gene plays a role in mitochondrial protein metabolism and could be involved in mitochondrial pathologies. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
YME1L1 Gene-Disease associations (from GenCC):
- autosomal recessive optic atrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- optic atrophy 11Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-27111932-G-A is Benign according to our data. Variant chr10-27111932-G-A is described in ClinVar as Benign. ClinVar VariationId is 1259033.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.967 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| YME1L1 | NM_014263.4 | c.*45C>T | 3_prime_UTR_variant | Exon 19 of 19 | ENST00000376016.8 | NP_055078.1 | ||
| YME1L1 | NM_139312.3 | c.*45C>T | 3_prime_UTR_variant | Exon 20 of 20 | NP_647473.1 | |||
| YME1L1 | NM_001253866.2 | c.*45C>T | 3_prime_UTR_variant | Exon 18 of 18 | NP_001240795.1 | |||
| YME1L1 | XM_011519300.4 | c.*45C>T | 3_prime_UTR_variant | Exon 19 of 19 | XP_011517602.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| YME1L1 | ENST00000376016.8 | c.*45C>T | 3_prime_UTR_variant | Exon 19 of 19 | 1 | NM_014263.4 | ENSP00000365184.3 | |||
| YME1L1 | ENST00000326799.7 | c.*45C>T | 3_prime_UTR_variant | Exon 20 of 20 | 1 | ENSP00000318480.3 | ||||
| YME1L1 | ENST00000427324.6 | c.*45C>T | 3_prime_UTR_variant | Exon 18 of 18 | 3 | ENSP00000398713.2 | ||||
| YME1L1 | ENST00000491542.7 | c.*45C>T | 3_prime_UTR_variant | Exon 16 of 16 | 2 | ENSP00000473557.2 |
Frequencies
GnomAD3 genomes AF: 0.855 AC: 130115AN: 152116Hom.: 55954 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
130115
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.848 AC: 212727AN: 250992 AF XY: 0.849 show subpopulations
GnomAD2 exomes
AF:
AC:
212727
AN:
250992
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.833 AC: 1215175AN: 1457950Hom.: 507835 Cov.: 32 AF XY: 0.835 AC XY: 605624AN XY: 725532 show subpopulations
GnomAD4 exome
AF:
AC:
1215175
AN:
1457950
Hom.:
Cov.:
32
AF XY:
AC XY:
605624
AN XY:
725532
show subpopulations
African (AFR)
AF:
AC:
29971
AN:
33426
American (AMR)
AF:
AC:
32872
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
22121
AN:
26116
East Asian (EAS)
AF:
AC:
39052
AN:
39644
South Asian (SAS)
AF:
AC:
75360
AN:
86182
European-Finnish (FIN)
AF:
AC:
48817
AN:
52736
Middle Eastern (MID)
AF:
AC:
4597
AN:
5750
European-Non Finnish (NFE)
AF:
AC:
911691
AN:
1109086
Other (OTH)
AF:
AC:
50694
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
9992
19984
29977
39969
49961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20898
41796
62694
83592
104490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.855 AC: 130205AN: 152234Hom.: 55993 Cov.: 32 AF XY: 0.863 AC XY: 64264AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
130205
AN:
152234
Hom.:
Cov.:
32
AF XY:
AC XY:
64264
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
37272
AN:
41542
American (AMR)
AF:
AC:
11841
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
2957
AN:
3468
East Asian (EAS)
AF:
AC:
5132
AN:
5186
South Asian (SAS)
AF:
AC:
4283
AN:
4822
European-Finnish (FIN)
AF:
AC:
9884
AN:
10608
Middle Eastern (MID)
AF:
AC:
227
AN:
292
European-Non Finnish (NFE)
AF:
AC:
56129
AN:
68012
Other (OTH)
AF:
AC:
1752
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
944
1889
2833
3778
4722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3241
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 16, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Optic atrophy 11 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.